Medical Weight Loss for Dundalk, Maryland Residents
Dundalk, Maryland residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Dundalk through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Dundalk Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Dundalk, Maryland through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
Medical weight loss for Dundalk is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.
Patients across Dundalk and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Maryland. We care for patients throughout Dundalk and the southeastern Baltimore County waterfront. Whether you are starting your first GLP-1 program or switching from a brand medication, your Dundalk treatment plan is built around your health history and goals.
Our telehealth model serves Dundalk and communities across Maryland with the same flat pricing and the same supervising physician. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Dundalk patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Dundalk
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Dundalk address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Dundalk
Does New Hope Weight Loss treat patients in Dundalk?
Yes. Although the clinic is in Costa Mesa, California, we treat Dundalk, Maryland residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Dundalk?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Dundalk address in cold-pack packaging.
What do Dundalk patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Dundalk do you serve?
We serve patients from across Dundalk by telehealth, including Dundalk and the southeastern Baltimore County waterfront.
Is my health information private as a Dundalk patient?
Yes. Your intake, video visits, and records are handled under HIPAA safeguards, and medication arrives in discreet packaging. Dundalk patients get the same confidentiality as any telehealth patient.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Dundalk, Maryland by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.